Miscellaneous Quiz / Opioids

Random Miscellaneous Quiz

Can you name the Opioids?

Quiz not verified by Sporcle

Forced Order
Score 0/81 Timer 20:00
Medium oral potency. DOA 3-4 hours
Receptor subtype: Mu (P) and Kappa (+++)
Drug use: Analgesia (severe acute pain), pre-sx anxiolytic, epidural & spinal analgesia, balanced anesthesia, chronic pain (patches, lollipops)
Efficacy: high; abuse potential: low
SE: in dependent pts --> instant abstinence (withdrawal syndrome)
Analgesia (severe acute pain), pre-sx anxiolytic, epidural & spinal regional analgesia, balanced anesthesia, dyspnea.
Butorphanol class
Non-opioid effects: MAO inhibition, blocks NMDA (neuropathic pain)
Receptor subtype: Mu (+)
Parenteral only. DOA: 3-4 hours
High oral bioavailability.DOA: 4-6 hours
Naloxone class
Receptor subtype: Mu (P) and Delta (++)
Pentazocine class
Drug use: acute opioid OD
SE: Increased tone of the ureter, bladder, and sphincter (--> urinary retention), decreased uterine tone (may prolong labor).
Hydrocodone w/ acetaminophen
Drug MOA: Weak mu-receptor agonist. Serotonin and NE transporter inhibition
Meperidine class
Parenteral. DOA: > 1.5 hours
Levorphanol class
Receptor subtype: Mu (--) and Kappa (++)
Efficacy: moderate; abuse potential: medium
Codeine w/acetaminophen
Drug use: mild to moderate analgesia, anti-tussives
Buprenorphine class
Oxycodone class
Oxycodone w/ aspirin
Drug use: Analgesia, pre-sx anxiolytic, epidural & spinal analgesia, balanced anesthesia (buprenorphine may be > effective than methadone in detox & maintenance tx in heroin users
Oxycodone w/ acetaminophen
Receptor subtype: Mu (P) and Kappa (--)
Oral only. DOA 4-5 hours
SE: Neuroendocrine effects (stimulate the release of ADH, prolactin, somatotropin, inhibit the release of LH), pruritis, flushing, warm skin, sweating.
SE: Resp depression (increased PaCO2 & depressed response to CO2 challenge), cough suppression, miosis, truncal rigidity, n/v, little effect on BP or HR (some exceptions)
Medium oral bioavailability. DOA: 2-4 hours
Efficacy: high; abuse potential: high
SE: Itching (via histamine release), immune modulation
Medium oral bioavailability, not SC (irritant). DOA: 3-4 hours
Well absorbed orally. Strong first pass effect. DOA: up to 48 hours
Efficacy: moderate. Abuse Potential: low
High oral potency. DOA 3-4 hours
Efficacy: very low; abuse potential: low
Dihydrocodone class
Drug use: Mild to moderate analgesia
Receptor subtype: Mu (+++) and Kappa (+)
Tramadol class
SE: Peripheral arterial & venous dilation, may increase ICP when pCO2 rises, constipation, decreased motility, increase in GI tone & spasms, biliary colic
SE: Constriction of Oddi sphincter (--> reflex of bile and pancreatic juice --> elevated plasma amylase, lipase), depressed renal function.
Transdermal, low oral bioavailability. DOA: >1.5 hours
SE: seizures, neuropathic pain. Little respiratory effects
Drug use: detox tx for heroine addicts, tolerance develops slower -- analgesic rotation. Withdrawal milder; maintenance tx for heroin addicts
Addiction/Withdrawal: No tolerance develops, no abstinence symptoms after withdrawal of antagonists after chronic administration
Drug use: Analgesia (especially severe acute pain)
Nalbuphine class
Low oral bioavailability. DOA: 3-4 hours
Receptor subtype: Mu (+++)
Efficacy: low; abuse potential: medium
Methadone class
Receptor subtype: Mu (++) [10% to morphine] and Delta (+)
Codeine w/ aspirin
Parenteral. DOA: > 0.05 hours
Non-opioid effects: Antimuscarinic, (tachycardia), blocks serotonin reuptake (contraindicated w/ MAOIs), active metabolite can produce seizure in pts w/ renal failure
Drug: Poor oral efficacy. Glucoronidation. DOA: 1-2 hours (IV). Repeated injected may be needed
Fentanyl class
Drug use: Mild analgesia, 1/2 as potent as codeine
Hydrocodone class
Drug Effects: Almost inert in the absence of an agonist. Reverses opioid effect completely in 1 - 3 minutes. Normalizes resp, consciousness, pupil size, & bowel activity.
SE: Analgesia, euphoria (floating sensation, no anxiety or distress), rarely dysphoria (restlessness, malaise), sedation, drowsiness.
Drug use: acute opioid OD, possible use in decreasing ETOH cravings in addicts
Receptor subtype: Mu (+++), Delta (+), and Kappa (+)
Hydrocodone w/ ibuprofen
Codeine class
Nalmefene class
Low oral bioavailability. DOA: 4-5 hours
IV only with DOA longer than naloxone
Parenteral. DOA: > 0.75 hours
Parenteral or SL only. DOA: > 8 hours. Long half life (20-70 hours)
Receptor subtype: Mu (P) and Kappa (++)
Naltrexone class
Dezocine class
Parenteral only. DOA: 4-8 hours

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
Log In

You Might Also Like...

Show Comments


Top Quizzes Today

Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.